Skip to content

Revolution Medicines, Inc. RVMD Amortization of capitalized software and acquired intangible assets

Amortization of capitalized software and acquired intangible assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$437M-47.3%
TransDigm Group logo
TransDigm GroupTDG
$61M+27.1%
Intuitive Surgical logo
Intuitive SurgicalISRG
$21.1M+74.4%
Verisk Analytics, Inc. logo
Verisk Analytics, Inc.VRSK
$14.4M-8.9%
TTM Technologies logo
TTM TechnologiesTTMI
$6.89M0.0%
PTC logo
PTCPTC
$12.01M+5.6%

Other financials

Income statement

See full
Revenue-
Operating income-$445.2M-84.9%
Net income-$453.8M-113%
EPS (diluted)-$2.29-103%

Balance sheet

See full
Cash & equivalents$440.9M+32.2%
Total debt$156.6M+16.6%
Total equity$1.5B-27.8%
Total assets$2.3B-4.7%

Cash flow

See full
Operating cash flow-$354.2M-82.2%
CapEx$1.5M-52.9%
Free cash flow-$355.7M-79.9%

Valuation

See full
Market cap$34.65B+193%
Enterprise value$34.37B+198%

Profitability

See full
Operating margin-88,031.9%-89,488pp
Net margin-76,423.3%-77,733pp

Returns & leverage

See full
Return on equity-76.7%-923pp
Debt / equity0.1×0.0×
Current ratio6.8×-6.7×

Where this comes from

Reported directly by Revolution Medicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revolution Medicines, Inc.'s amortization of capitalized software and acquired intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Revolution Medicines, Inc.'s amortization of capitalized software and acquired intangible assets?
Revolution Medicines, Inc. (RVMD) reported amortization of capitalized software and acquired intangible assets of $0 in Q1 2026.
How has Revolution Medicines, Inc.'s amortization of capitalized software and acquired intangible assets changed year-over-year?
Revolution Medicines, Inc.'s amortization of capitalized software and acquired intangible assets decreased by 100.0% year-over-year, from $267K to $0.
What is the long-term trend for Revolution Medicines, Inc.'s amortization of capitalized software and acquired intangible assets?
Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s amortization of capitalized software and acquired intangible assets has grown at a -4.7% compound annual growth rate (CAGR), from $1.13M to $936K.